Note: This message is displayed if (1) your browser is not standards-compliant or (2) you have you disabled CSS. Read our Policies for more information.
Indiana Epidemiology Newsletter
The ISDH will host the 2007 Public Health Nurse Conference on Friday, June 8, at the Indiana Government Center South. Based on your feedback and surveys from last year’s program, we have designed this year’s program to include concurrent breakout sessions based on topics of interest you suggested. We will also allow for a longer lunch break. Free parking is available at the Indiana State Government Center South garage by presenting the coupon at the bottom of the registration form.
|9:00-9:15||Welcome/Introductions||Judith A. Monroe, M.D.; Mary Hill (invited)|
|9:15-9:30||PHESS Update||Ryan Gentry|
|9:30-9:45||Cultural Competence||Antoniette Holt|
|9:45-10:10||Vaccine-Preventable Disease||Wayne Staggs, Karee Buffin|
|10:20-11:10||Concurrent Session 1|
|11:10-12:30||Lunch (on your own)|
|12:30-1:20||Concurrent Session 2|
|1:30-2:20||Concurrent Session 3|
|2:30-3:30||Outbreak Case Study||Pam Pontones|
|Case Investigation/Surveillance||Jim Howell, Tracy Powell|
|Tuberculosis||Sarah Burkholder, Tina Feaster, Shameer Poonja|
|HIV/STD Investigation||Bell Flower Clinic Disease Intervention Specialists|
|Hepatitis A-E||Jean Svendsen, Mike Wilkinson, Lynae Granzow|
We have designed the concurrent sessions to provide more in-depth discussion about topics last year’s participants suggested in the surveys. Although concurrent session seating is limited to 25 participants, we will offer each session all three times. Participants may choose which three sessions they would like to attend. Following the conference, we plan to provide all local health departments with a CD that will include all sessions.
Case Investigation/Surveillance will provide information helpful to new(er) public health nurses. This session will focus on the importance of reportable disease surveillance and will discuss what diseases are reportable, who needs to report, completing and submitting case investigation forms, and how reportable disease data are used at the ISDH. This will also be an opportunity to discuss barriers and solutions to reporting and the future of reportable disease surveillance. This session will include other “Public Health 101” information.
Tuberculosis will focus on “TB 101” for public health nurses, including case and contact investigations, direct observed therapy (DOT), and treatment options. Current TB statistics for Indiana and available resources will also be discussed.
Outbreak/Epi-Ready will describe outbreak investigations, including the investigation process, roles and responsibilities of the investigation team, basic principles of epidemiology, and laboratory specimen collection.
HIV/STD Investigation will focus on case investigation of HIV and sexually transmitted diseases. This is an honest and open discussion on conducting case interviews, including the current terminology, sensitive questions, trends, and risk factors.
Hepatitis A-E will describe five types of viral hepatitis, including case definitions, disease progression, case investigations and reporting, acute versus chronic cases, and interpretation of laboratory results.